Similar to the enhanced LC3-II turnover, combination with CQ resulted in a marked accumulation of p62 compared with treatment alone, suggesting that autophagy inhibitors blocked combined treatment-triggered autophagic flux in NSCLC cells. Here, SQSTM1 is linked to non-small cell lung carcinoma.